** Shares of health insurer Oscar Health Inc OSCR.N up
1.8% at $8.50
** BofA Global Research upgrades stock rating to "neutral"
from "underperform" and raises PT to $8.75 from $5.40
** OSCR expects to hit the target it laid out back in 2021
at the time of its IPO, to achieve insurance segment
profitability
** Brokerage says co should be well positioned to grown in
2024 without a significant cash drag from funding subsidiary
growth
** Also optimistic on company's new CEO, Mark Bertolini,
former chief of health insurance giant Aetna Inc; says he brings
a proven track record of execution
** BofA, however, remains somewhat cautious about fully
underwriting the margin targets co plans to achieve
** Including session's gain, OSCR up 243.5% YTD
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com;))